控制- iq自动胰岛素输送对2型糖尿病患者基础注射和仅基础注射胰岛素的有益影响

Q2 Medicine

Clinical Diabetes Pub Date : 2024-01-01 Epub Date: 2023-08-28 DOI:10.2337/cd23-0025

Carol J Levy, Dan Raghinaru, Yogish C Kudva, Keta Pandit, Thomas Blevins, Luis Casaubon, Donna Desjardins, Camilla M Levister, Grenye O'Malley, Corey Reid, John Lum, Craig Kollman, Roy W Beck

{"title":"控制- iq自动胰岛素输送对2型糖尿病患者基础注射和仅基础注射胰岛素的有益影响","authors":"Carol J Levy, Dan Raghinaru, Yogish C Kudva, Keta Pandit, Thomas Blevins, Luis Casaubon, Donna Desjardins, Camilla M Levister, Grenye O'Malley, Corey Reid, John Lum, Craig Kollman, Roy W Beck","doi":"10.2337/cd23-0025","DOIUrl":null,"url":null,"abstract":"The t:slim X2 insulin pump with Control-IQ technology (Control-IQ) advanced hybrid closed-loop automated insulin delivery system was evaluated in this prospective single-arm trial. Thirty adults with type 2 diabetes using the Control-IQ system showed substantial glycemic improvement with no increase in hypoglycemia. Mean time in range (70-180 mg/dL) improved 15%, representing an increase of 3.6 hours/day, and mean glucose decreased by 22 mg/dL.","PeriodicalId":39894,"journal":{"name":"Clinical Diabetes","volume":" ","pages":"116-124"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10788662/pdf/","citationCount":"0","resultStr":"{\"title\":\"Beneficial Effects of Control-IQ Automated Insulin Delivery in Basal-Bolus and Basal-Only Insulin Users With Type 2 Diabetes.\",\"authors\":\"Carol J Levy, Dan Raghinaru, Yogish C Kudva, Keta Pandit, Thomas Blevins, Luis Casaubon, Donna Desjardins, Camilla M Levister, Grenye O'Malley, Corey Reid, John Lum, Craig Kollman, Roy W Beck\",\"doi\":\"10.2337/cd23-0025\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The t:slim X2 insulin pump with Control-IQ technology (Control-IQ) advanced hybrid closed-loop automated insulin delivery system was evaluated in this prospective single-arm trial. Thirty adults with type 2 diabetes using the Control-IQ system showed substantial glycemic improvement with no increase in hypoglycemia. Mean time in range (70-180 mg/dL) improved 15%, representing an increase of 3.6 hours/day, and mean glucose decreased by 22 mg/dL.\",\"PeriodicalId\":39894,\"journal\":{\"name\":\"Clinical Diabetes\",\"volume\":\" \",\"pages\":\"116-124\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10788662/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Diabetes\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2337/cd23-0025\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/8/28 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Diabetes","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2337/cd23-0025","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/8/28 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

在这项前瞻性单臂试验中，对采用Control IQ技术（Control IQ）的t:slim X2胰岛素泵进行了评估。使用Control IQ系统的30名患有2型糖尿病的成年人血糖显著改善，低血糖症没有增加。在范围（70–180 mg/dL）内的平均时间改善了15%，即每天增加3.6小时，平均葡萄糖减少了22 mg/dL。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Beneficial Effects of Control-IQ Automated Insulin Delivery in Basal-Bolus and Basal-Only Insulin Users With Type 2 Diabetes.

The t:slim X2 insulin pump with Control-IQ technology (Control-IQ) advanced hybrid closed-loop automated insulin delivery system was evaluated in this prospective single-arm trial. Thirty adults with type 2 diabetes using the Control-IQ system showed substantial glycemic improvement with no increase in hypoglycemia. Mean time in range (70-180 mg/dL) improved 15%, representing an increase of 3.6 hours/day, and mean glucose decreased by 22 mg/dL.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Clinical Diabetes Medicine-Internal Medicine

CiteScore

4.30

自引率

0.00%

发文量

期刊介绍： The mission of Clinical Diabetes is to provide primary care providers and all clinicians involved in the care of people with diabetes with information on advances and state-of-the-art care for people with diabetes. Clinical Diabetes is also a forum for discussing diabetes-related problems in practice, medical-legal issues, case studies, digests of recent research, and patient education materials.